BIOMAT Database Logo BIOMAT Database Logo

In vitro activity of SCH-34343, a new penam, and other antimicrobial agents against clinical isolates from cancer patients. 1986

K V Rolston, and M E Alvarez, and J F Hoy, and H C Alderman, and D H Ho, and G P Bodey

The in vitro activity of SCH-34343, a new penam antibiotic, was tested against gram-positive and gram-negative isolates from cancer patients, and compared to that of 7 other antimicrobial agents. SCH-34343 was extremely active against the Enterobacteriaceae with MIC90 ranging from 0.39 to 6.25 micrograms/ml for Citrobacter spp., Enterobacter spp., Escherichia coli, Klebsiella spp., Proteus spp. and Serratia marcescens. It was less active against Acinetobacter spp. (MIC90 6.25-12.5 micrograms/ml) and had poor activity against Pseudomonas aeruginosa. Among gram-positive isolates group A and G beta-hemolytic Streptococci were extremely susceptible to SCH-34343 (MIC90 0.025-0.05 micrograms/ml). Good activity against methicillin-susceptible coagulase-positive and coagulase-negative Staphylococci and Listeria monocytogenes, and moderate activity against Enterococci was also seen.

UI MeSH Term Description Entries
D007769 Lactams Cyclic AMIDES formed from aminocarboxylic acids by the elimination of water. Lactims are the enol forms of lactams. Lactam,Lactim,Lactims
D008089 Listeria monocytogenes A species of gram-positive, rod-shaped bacteria widely distributed in nature. It has been isolated from sewage, soil, silage, and from feces of healthy animals and man. Infection with this bacterium leads to encephalitis, meningitis, endocarditis, and abortion.
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D004755 Enterobacteriaceae A family of gram-negative, facultatively anaerobic, rod-shaped bacteria that do not form endospores. Its organisms are distributed worldwide with some being saprophytes and others being plant and animal parasites. Many species are of considerable economic importance due to their pathogenic effects on agriculture and livestock. Coliform Bacilli,Enterobacteria,Ewingella,Leclercia,Paracolobactrum,Sodalis
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria
D006094 Gram-Positive Bacteria Bacteria which retain the crystal violet stain when treated by Gram's method. Gram Positive Bacteria
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013210 Staphylococcus A genus of gram-positive, facultatively anaerobic, coccoid bacteria. Its organisms occur singly, in pairs, and in tetrads and characteristically divide in more than one plane to form irregular clusters. Natural populations of Staphylococcus are found on the skin and mucous membranes of warm-blooded animals. Some species are opportunistic pathogens of humans and animals.

Related Publications

K V Rolston, and M E Alvarez, and J F Hoy, and H C Alderman, and D H Ho, and G P Bodey
Comparative in-vitro activity of Sch 34343 and other antimicrobial agents against anaerobic bacteria.
June 1985, The Journal of antimicrobial chemotherapy,
K V Rolston, and M E Alvarez, and J F Hoy, and H C Alderman, and D H Ho, and G P Bodey
BMY28142, cefbuperazone (T-1982), and Sch 34343. Antimicrobial activity against 94 anaerobes compared to seven other antimicrobial agents.
May 1985, Diagnostic microbiology and infectious disease,
K V Rolston, and M E Alvarez, and J F Hoy, and H C Alderman, and D H Ho, and G P Bodey
In vitro activity of Sch 34343 against enterococci and other gram-positive bacteria.
January 1985, Antimicrobial agents and chemotherapy,
K V Rolston, and M E Alvarez, and J F Hoy, and H C Alderman, and D H Ho, and G P Bodey
In-vitro activity of Sch 34343 against anaerobic bacteria.
June 1985, The Journal of antimicrobial chemotherapy,
K V Rolston, and M E Alvarez, and J F Hoy, and H C Alderman, and D H Ho, and G P Bodey
In vitro activity of Sch 34343 and cefbuperazone against anaerobic bacteria.
May 1985, Antimicrobial agents and chemotherapy,
K V Rolston, and M E Alvarez, and J F Hoy, and H C Alderman, and D H Ho, and G P Bodey
In vitro antimicrobial activity of gatifloxacin compared with other quinolones against clinical isolates from cancer patients.
November 2004, Chemotherapy,
K V Rolston, and M E Alvarez, and J F Hoy, and H C Alderman, and D H Ho, and G P Bodey
Comparative in-vitro activity of Sch 34343, a new penem antibiotic.
June 1985, The Journal of antimicrobial chemotherapy,
K V Rolston, and M E Alvarez, and J F Hoy, and H C Alderman, and D H Ho, and G P Bodey
In vitro activity of cefixime (CL284635) and other antimicrobial agents against Haemophilus isolates from pediatric patients.
January 1988, Chemotherapy,
K V Rolston, and M E Alvarez, and J F Hoy, and H C Alderman, and D H Ho, and G P Bodey
Comparative in vitro activity of Sch 34343 against urea-splitting microorganisms.
December 1985, European journal of clinical microbiology,
K V Rolston, and M E Alvarez, and J F Hoy, and H C Alderman, and D H Ho, and G P Bodey
In-vitro evaluation of Sch 34343: antimicrobial activity, beta-lactamase stability and inhibition.
June 1985, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!